Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UB-421 Monotherapy Substitution in HIV
NCT02369146Phase 2Completed
- Sponsor
- United BioPharma
- Start
- Jun 2015
- Primary completion
- Jul 2016
- Modality
- IgG Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of semzuvolimab in human immunodeficiency virus type 1 infection (HIV-1), sponsored by United BioPharma. Started Jun 2015; status: completed.
02
Drugs
semzuvolimab
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02369146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02369146.